Compare VIMTA LABS with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIMTA LABS vs HEALTHCARE GLOBAL ENTER. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VIMTA LABS HEALTHCARE GLOBAL ENTER. VIMTA LABS/
HEALTHCARE GLOBAL ENTER.
 
P/E (TTM) x 27.8 -57.0 - View Chart
P/BV x 4.8 5.4 88.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 VIMTA LABS   HEALTHCARE GLOBAL ENTER.
EQUITY SHARE DATA
    VIMTA LABS
Mar-21
HEALTHCARE GLOBAL ENTER.
Mar-21
VIMTA LABS/
HEALTHCARE GLOBAL ENTER.
5-Yr Chart
Click to enlarge
High Rs193193 99.9%   
Low Rs5963 94.1%   
Sales per share (Unadj.) Rs95.380.5 118.4%  
Earnings per share (Unadj.) Rs9.7-17.6 -55.0%  
Cash flow per share (Unadj.) Rs20.1-4.9 -410.0%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs87.951.6 170.5%  
Shares outstanding (eoy) m22.11125.36 17.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.31.6 83.2%   
Avg P/E ratio x13.0-7.3 -179.1%  
P/CF ratio (eoy) x6.3-26.1 -24.0%  
Price / Book Value ratio x1.42.5 57.8%  
Dividend payout %20.70-   
Avg Mkt Cap Rs m2,78816,055 17.4%   
No. of employees `000NANA-   
Total wages/salary Rs m5781,959 29.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2,10710,092 20.9%  
Other income Rs m8212 3.9%   
Total revenues Rs m2,11510,304 20.5%   
Gross profit Rs m530289 183.3%  
Depreciation Rs m2311,592 14.5%   
Interest Rs m221,192 1.8%   
Profit before tax Rs m285-2,283 -12.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71-76 -94.4%   
Profit after tax Rs m214-2,207 -9.7%  
Gross profit margin %25.12.9 878.2%  
Effective tax rate %25.03.3 754.9%   
Net profit margin %10.2-21.9 -46.5%  
BALANCE SHEET DATA
Current assets Rs m1,1054,350 25.4%   
Current liabilities Rs m5394,652 11.6%   
Net working cap to sales %26.9-3.0 -895.6%  
Current ratio x2.10.9 219.3%  
Inventory Days Days1856 33.1%  
Debtors Days Days12767 188.6%  
Net fixed assets Rs m1,62915,663 10.4%   
Share capital Rs m441,254 3.5%   
"Free" reserves Rs m1,9005,211 36.5%   
Net worth Rs m1,9446,465 30.1%   
Long term debt Rs m1423,462 4.1%   
Total assets Rs m2,73420,013 13.7%  
Interest coverage x14.2-0.9 -1,546.7%   
Debt to equity ratio x0.10.5 13.7%  
Sales to assets ratio x0.80.5 152.8%   
Return on assets %8.6-5.1 -169.9%  
Return on equity %11.0-34.1 -32.3%  
Return on capital %14.7-11.0 -133.9%  
Exports to sales %26.90-   
Imports to sales %11.50-   
Exports (fob) Rs m566NA-   
Imports (cif) Rs m243NA-   
Fx inflow Rs m566196 288.3%   
Fx outflow Rs m24319 1,269.3%   
Net fx Rs m323177 182.5%   
CASH FLOW
From Operations Rs m3721,205 30.9%  
From Investments Rs m-319-1,711 18.7%  
From Financial Activity Rs m-461,122 -4.1%  
Net Cashflow Rs m7617 1.1%  

Share Holding

Indian Promoters % 37.5 14.7 254.1%  
Foreign collaborators % 0.0 53.7 -  
Indian inst/Mut Fund % 1.4 15.4 9.1%  
FIIs % 0.0 7.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 62.5 31.6 197.9%  
Shareholders   19,947 20,573 97.0%  
Pledged promoter(s) holding % 0.0 16.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VIMTA LABS With:   VA TECH WABAG    SANGHVI MOVERS    DELTA CORP    SYNGENE INTERNATIONAL    RATTANINDIA ENTERPRISES    



Today's Market

Sensex Ends 86 Points Higher; Hero MotoCorp, Grasim & ONGC Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.

Related Views on News

HEALTHCARE GLOBAL ENTER. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of HEALTHCARE GLOBAL ENTER. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of HEALTHCARE GLOBAL ENTER.. Also includes updates on the valuation of HEALTHCARE GLOBAL ENTER..

VIMTA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Nov 2, 2021 | Updated on Nov 2, 2021

Here's an analysis of the annual report of VIMTA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of VIMTA LABS. Also includes updates on the valuation of VIMTA LABS.

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

Omicron: Sectors to Buy and Avoid in 2022 (Views On News)

Jan 11, 2022

We take a look at how stocks of 6 major sectors were impacted, the last time lockdowns were imposed and what we can learn from it.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VIMTA LABS SHARE PRICE


Jan 17, 2022 (Close)

TRACK VIMTA LABS

  • Track your investment in VIMTA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE VIMTA LABS WITH

MARKET STATS